Blog

ASLS wins the NH Tech Alliance Product of the Year award for 2025, recognizing the BioAssembly™ Platform as a breakthrough in 3D bioprinting and automated tissue manufacturing.

Discover best practices for streamlining complex organoid research with automation. Learn how Advanced Solutions Life Sciences combines robotics, software intelligence, and optimized fluidics to improve reproducibility, scalability, and experimental reliability.

Profound and Positive Podcast We’re excited to announce the launch of our brand-new podcast series, Profound and Positive   - where we explore how Advanced Solutions’ technologies are making profound and positive impacts on scientific discovery and biomedical research! Our mission with this series is simple: to open the lab doors and share real stories from scientists, engineers, and innovators who are pushing the boundaries of what’s possible. Each episode will feature conve

Organoid360™ is a turnkey automation platform designed for modern 3D biology and organoid research. Built on the BioAssemblyBot® and pre-configured with plug-and-play BioApps®, Organoid360 enables reproducible, high-throughput organoid workflows with minimal setup. Researchers can accelerate organoid assays, drug screening, and discovery while reducing hands-on time and variability.

Hannah A. Strobel, PhD | Staff Scientist | Advanced Solutions Life Sciences  Victoria Marsh, PhD | Director, Custom Organoid Services | Molecular Devices  Maria R. Oyaga, PhD | Scientist | Core Life Analytics  Angeline Lim, PhD | Applications Scientist | Molecular Devices    Introduction:   Patient-derived organoids (PDOs) are transforming how we approach drug and therapy development, offering more predictive models of patient responses. However, effectively utilizing these c

Discover the latest advancements in T-cell immunotherapies for cancer treatment.

Review the different considerations required for developing facilities centered around 3D bioprinting technologies.

3D structures made of collagen using mold design and fabrication

The BioAssemblyBot® Platform can be used to fabricate mesh or weave-like patterns to generate constructs with varying porosity.

Polydimethylsiloxane (PDMS) is a well-known and widely used viscoelastic biomaterial with applications across the tissue engineering.

One of the major differentiating factors between other types of additive manufacturing and bioprinting is the incorporation of biocompatible

The 2nd Australian Bioprinting Workshop for Tissue Engineering and Regenerative Medicine was a great success. University of Technology Sydney’s Department of Biomedical Engineering at the event, in partnership with 3D HEALS, curated an engaging and thought-provoking event with an attendance of over 500 people from leading local and international biotechnology companies, industry, academia and clinician representatives with widely regarded experts in the field. A key highligh

Advanced Solutions is pioneering the use of human-derived, isolated microvessel fragments in vasculatures in ex-vivo tissues and models.

The Buyer’s Guide is written to help technology enthusiasts and professionals find the right industrial 3D bioprinting system. The article’s author, Benedict O’Neill, provides immediate context for the audience by providing an exceptional definition of 3D bioprinting:

BioAssemblyBot gives users the ability to easily scan-and-3D bioprint living cells and tissues on complex surfaces – with six-axis freedom.

“We can print liver cells in a structure the size of a U.S. quarter and combine it with our vascularization technology in a 3D structure to get results that begin to mimic a functioning liver. “We have a model where we have to fail faster. Our objective, certainly from the engineering side, is to bring the market tools that allow the researchers, the biologists and the scientists to fail faster so they can move the biology forward.”